Allucent is structured from the CVC local workbook as a clinical cro provider with full service cro coverage.
Vendor description
Best suited for biotech teams that need a more advisory and integrated development partner.
Sponsors seeking clinical cro options in the Global coverage lane.
- Full-service CRO support from early-stage to post-approval for biotech and small-to-mid pharma
- Source workbook import only; external evidence enrichment still pending.
Approved customer reviews
Write a reviewBe the first customer to share verified experience with this vendor.
Review snapshot
Allucents public employee reviews lean moderately positive. Employees often mention good colleagues,autonomy,and solid work-life balance,but the negatives include systems friction,return-to-office tension for some teams,and uneven organizational maturity. The overall theme is a decent place to gain experience,especially if team fit is good.
Good colleagues - autonomy - work-life balance - experience-building
Systems friction - uneven maturity - return-to-office tension - variable team quality
Mixed-positive
Pricing
$
mid-market
Key facts
| HQ country | United States |
|---|---|
| Geography | Global |
| Service model | Clinical + regulatory + pharmacovigilance |
| Customer segment | mixed |
| Study phases | Phase I, Phase II, Phase III, Phase IV |
| Trial scale | Mid-size programmes and emerging biotech portfolios |
| Therapeutic areas | Generalist, Rare disease |
| Last reviewed | 2026-03-28 |
Related vendors
Editorial ranking
See how Allucent compares - best Specialist CRO vendors for clinical trials.




